Sandeep Laumas, M.D.
Executive Chairman
Sandeep Laumas
Dr. Laumas joined Innovate Biopharmaceuticals in 2014 as Executive Chairman.  Dr. Laumas founded Bearing Circle Capital in 2008 and has been its Chief Executive Officer since 2008. He started his career at Goldman Sachs in 1996 as an equity analyst in the Healthcare Investment Banking division working on mergers, acquisitions, and corporate finance transactions before transitioning to the Healthcare Equity Research division. After leaving Goldman Sachs in 2000, Dr. Laumas moved to the buy side as an Analyst at Balyasny Asset Management from 2001 to 2003. Dr. Laumas was the Managing Director of North Sound Capital from 2003 to 2007, where he was responsible for their global healthcare investment portfolio. Since February 2011, he has been a Director for Super Religare Laboratories Limited, Southeast Asia’s largest clinical laboratory. Dr. Laumas also served as a Director of Parkway Holdings Ltd. (IHH Healthcare Bhd.: Singapore: IHH) from May through August 2010. Dr. Laumas received his A.B. in Chemistry from Cornell University in 1990, M.D. in Medicine from Albany Medical College in 1995 and completed his medical internship in 1996 from the Yale University School of Medicine.
Chairman of the Board
    Christopher P. Prior, Ph.D.
    Chief Executive Officer
    Christopher P. Prior, Ph.D.
    Dr. Prior is a recognized industry leader both as a developer of important new therapeutics and as an accomplished serial entrepreneur. Over the course of his 30-year career, he has generated more than 25 INDs and achieved four product approvals. In addition, he founded, built-up and sold two companies (Principia, BioRexis) in deal values exceeding $0.5 Billion. Chris joined Innovate in 2015 as Chief Executive Officer. Chris received a B.Sc. (honors) in chemistry from the University of London, a Ph.D. in biochemistry from Columbia University in New York City and a research fellowship at The Rockefeller Medical Institute (New York). Chris is a member of the New York Academy of Sciences and is the author of numerous publications and patents focused on the development of therapeutics.
      Jay P. Madan, M.S.
      Founder, President and Chief Business Officer
      Jay P. Madan
      Mr. Madan founded Innovate Biopharmaceuticals in 2013 and has spent more than two decades in life sciences/biotech as a leader in M&A, technology transfer, cross border licensing and project development.  Mr. Madan’s experience in working across multiple teams at Reliance Life Sciences, Millipore, Baxter, Dade Behring, and Goodwin led him to develop a global network of healthcare professionals. He was the VP of Business Development at Reliance Biopharmaceuticals Pvt. Ltd. part of Reliance Industries Ltd., India’s largest conglomerate. Both at Reliance and Goodwin, he was focused on the development of their contract manufacturing businesses. Mr. Madan holds a Bachelor of Chemical Engineering from University of Mumbai and an M.S. in Chemical Engineering from Washington State University.
      Financial Expert

        Copyright Nasdaq. Minimum 15 minutes delayed.